medigraphic.com
ISSN 2007-6800 (Impreso)

2020, Número S1

<< Anterior Siguiente >>

Rev Mex Traspl 2020; 9 (S1)


Enfermedad ósea metabólica renal en el potencial receptor de trasplante renal

Ramírez-Sandoval JC

Idioma: Español
Referencias bibliográficas: 37
Paginas: 68-74
Archivo PDF: 248.92 Kb.


FRAGMENTO

Los receptores candidatos a trasplante renal deberán tener al menos una medición de las concentraciones séricas de calcio, fósforo, albúmina y fosfatasa alcalina dentro del mes previo al trasplante y una medición de las concentraciones de hormona paratiroidea molécula intacta (iPTH) dentro de los 3-6 meses previo al trasplante (Obligatorio).


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011). 2017; 7 (1): 1-59.

  2. Bellorin-Font E, Ambrosoni P, Carlini RG, Carvalho AB, Correa-Rotter R, Cueto-Manzano A et al. Guías de práctica clínica para la prevención, diagnóstico, evaluación y tratamiento de los trastornos minerales y óseos en la enfermedad renal crónica (TMO-ERC) en adultos. Nefrologia. 2013; 33 (Suppl. 1): 1-28.

  3. Obi Y, Mehrotra R, Rivara MB, Streja E, Rhee CM, Lau WL et al. Hidden hypercalcemia and mortality risk in incident hemodialysis patients. J Clin Endocrinol Metab. 2016; 101 (6): 2440-2449.

  4. Björkman MP, Sorva AJ, Tilvis RS. Calculated serum calcium is an insufficient surrogate for measured ionized calcium. Arch Gerontol Geriatr. 2009; 49 (3): 348-350.

  5. Obi Y, Nguyen DV, Streja E, Rivara MB, Rhee CM, Lau WL et al. Development and validation of a novel laboratory-specific correction equation for total serum calcium and its association with mortality among hemodialysis patients. J Bone Miner Res. 2017; 32 (3): 549-559.

  6. Iimori S, Mori Y, Akita W, Kuyama T, Takada S, Asai T et al. Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients-a single-center cohort study. Nephrol Dial Transplant. 2012; 27 (1): 345-351.

  7. West SL, Lok CE, Langsetmo L, Cheung AM, Szabo E, Pearce D et al. Bone mineral density predicts fractures in chronic kidney disease. J Bone Miner Res. 2015; 30 (5): 913-919.

  8. Yenchek RH, Ix JH, Shlipak MG, Bauer DC, Rianon NJ, Kritchevsky SB et al. Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol. 2012; 7 (7): 1130-1136.

  9. Bouquegneau A, Salam S, Delanaye P, Eastell R, Khwaja A. Bone Disease after Kidney Transplantation. Clin J Am Soc Nephrol. 2016; 11 (7): 1282-1296.

  10. Monier-Faugere MC, Mawad H, Qi Q, Friedler RM, Malluche HH. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol. 2000; 11 (6): 1093-1099.

  11. Iyer SP, Nikkel LE, Nishiyama KK, Dworakowski E, Cremers S, Zhang C et al. Kidney transplantation with early corticosteroid withdrawal: paradoxical effects at the central and peripheral skeleton. J Am Soc Nephrol. 2014; 25 (6): 1331-1341.

  12. Akaberi S, Simonsen O, Lindergård B, Nyberg G. Can DXA predict fractures in renal transplant patients? Am J Transplant. 2008; 8 (12): 2647-2651.

  13. Keronen S, Martola L, Finne P, Burton IS, Kröger H, Honkanen E. Changes in bone histomorphometry after kidney transplantation. Clin J Am Soc Nephrol. 2019; 14 (6): 894-903.

  14. Ferreira GF, Montenegro FL de M, Machado DJ, Ianhez LE, Nahas WC, David-Neto E. Parathyroidectomy after kidney transplantation: short-and long-term impact on renal function. Clinics. 2011; 66 (3): 431-435.

  15. Schmid T, Müller P, Spelsberg F. Parathyroidectomy after renal transplantation: a retrospective analysis of long-term outcome. Nephrol Dial Transplant. 1997; 12 (11): 2393-2396.

  16. Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y. Natural history of parathyroid function and calcium metabolism after kidney transplantation: A single-centre study. Nephrol Dial Transplant. 2004; 19 (5): 1281-1287.

  17. Lou I, Foley D, Odorico SK, Leverson G, Schneider DF, Sippel RCH. How well does renal transplantation cure hyperparathyroidism? Ann Surg. 2015; 262 (4): 653-659.

  18. Reinhardt W, Bartelworth H, Jockenhövel F, Schmidt-Gayk H, Witzke O, Wagner K et al. Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant. 1998; 13 (2): 436-442.

  19. Lobo PI, Cortez MS, Stevenson WPT. Normocalcemic hyperparathyroidism associated with relatively low 1:25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol. Clin Nephrol. 1995; 9 (4): 277.

  20. Littbarski SA, Kaltenborn A, Gwiasda J, Beneke J, Arelin V, Schwager Y et al. Timing of parathyroidectomy in kidney transplant candidates with secondary hyperparathryroidism: effect of pretransplant versus early or late post-transplant parathyroidectomy. Surgery. 2018; 163 (2): 373-380.

  21. Callender GG, Malinowski J, Javid M, Zhang Y, Huang H, Quinn CE et al. Parathyroidectomy prior to kidney transplant decreases graft failure. Surgery. 2017; 161 (1): 44-50.

  22. Apetrii M, Goldsmith D, Nistor I, Siriopol D, Voroneanu L, Scripcariu D et al. Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (CKD-MBD)-A systematic review and meta-analysis. PLoS One. 2017; 12 (11): 1-17.

  23. FitzGerald RA, Sehgal AR, Nichols JA, McHenry CR. Factors predictive of emergency department visits and hospitalization following thyroidectomy and parathyroidectomy. Ann Surg Oncol. 2015; 22 Suppl 3: S707-S713.

  24. Isaksson E, Almquist M, Seeberger A, Sterner G. Is low pre-transplant parathyroid hormone a risk marker for cardiovascular disease in long-term follow-up of renal transplant recipients? Clin Exp Nephrol. 2018; 22 (5): 1188-1197.

  25. Messa P, Regalia A, Alfieri CM, Cresseri D, Forzenigo L, Gandolfo MT et al. Current indications to parathyroidectomy in CKD patients before and after renal transplantation. J Nephrol. 2013; 26 (6): 1025-1032.

  26. Moroni G, Tantardini F, Gallelli B, Quaglini S, Banfi G, Poli F et al. The long-term prognosis of renal transplantation in patients with lupus nephritis. Am J Kidney Dis. 2005; 45 (5): 903-911.

  27. Uhlig K, Berns JS, Kestenbaum B, Kumar R, Leonard MB, Martin KJ et al. KDOQI US Commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis. 2010; 55 (5): 773-799.

  28. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013; 3 (1): 4-4.

  29. Zhang L, Liu X, Li H. Long-term skeletal outcomes of primary hyperparathyroidism patients after treatment with parathyroidectomy: a systematic review and meta-analysis. Horm Metab Res. 2018; 50 (3): 242-249.

  30. Punch JD, Thompson NW, Merion RM. Subtotal parathyroidectomy in dialysis-dependent and post-renal transplant patients. A 25-year single-center experience. Arch Surg. 1995; 130 (5): 538-542; discussion 542-543.

  31. Tominaga Y, Uchida K, Haba T, Katayama A, Sato T, Hibi Y et al. More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis. 2001; 38 (4 Suppl 1): S168-S171.

  32. Sato T, Tominaga Y, Ueki T, Goto N, Matsuoka S, Katayama A et al. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism. Am J Kidney Dis. 2004; 44 (3): 481-487.

  33. Dulfer RR, Franssen GJH, Hesselink DA, Hoorn EJ, van Eijck CHJ, van Ginhoven TM. Systematic review of surgical and medical treatment for tertiary hyperparathyroidism. Br J Surg. 2017; 104 (7): 804-813.

  34. Matstusoka S, Tominaga Y, Uno N, Goto N, Sato T, Katayama A et al. Calciphylaxis: a rare complication of patients who required parathyroidectomy for advanced renal hyperparathyroidism. World J Surg. 2005; 29 (5): 632-635.

  35. Checheriţă IA, Smarandache D, David C, Ciocâlteu A, Ion DA, Lascăr I. Vascular calcifications in chronic kidney disease--clinical management. Rom J Morphol Embryol. 2012; 53 (1): 7-13.

  36. Nigwekar SU, Brunelli SM, Meade D, Wang W, Hymes J, Lacson E. Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clin J Am Soc Nephrol. 2013; 8 (7): 1162-1170.

  37. DeLoach SS, Joffe MM, Mai X, Goral S, Rosas SE. Aortic calcification predicts cardiovascular events and all-cause mortality in renal transplantation. Nephrol Dial Transplant. 2009; 24 (4): 1314-1319.




2020     |     www.medigraphic.com